Latest in Approvals, Safety & REMS

Approvals, Safety & REMS at a glance

The 10 latest articles on Approvals, Safety & REMS come from 9 sources, published between Nov 2 and Nov 12. Most come from BIOENGINEER.ORG (2).

People in these stories: Moderna (4), Alessandra Carneiro (2)

Organizations: Moderna (2), Pfizer (2)

Places: Canada (5), Europe (4), United States (2)

181 words

Immuneering to Highlight Atebimetinib’s Broad Potential for Combinations in Pancreatic and Anaplastic Thyroid Cancers at the 2026 EORTC-NCI-AACR Symposium

- Atebimetinib in combination with chemotherapy has shown excellent results in Phase 2 clinical trials, including 17.3 months median overall survival in first-line pancreatic cancer patients treated with atebimetinib + mGnP, as presented in June at ASCO - - Poster spotlight session will highlight broad set…

Approvals, Safety & REMS

FDA/EMA decisions, boxed warnings, pharmacovigilance, and label changes.

  • 4 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.